Envista Holdings Corporation has grown revenue 3.4% a year over three years and 3.4% a year over five, with earnings per share compounding at −22%. Revenue growth, 3-year annual rate: +3.4% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +3.4%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −22%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 9, FY2017 to FY2025, as filed.

NVSTEnvista Holdings Corporation

Healthcare

$22.99+9.8% 1Y

$22.99

$18.9552 weeks$30.26

Is it growing?

Excellent

Growing: revenue growing +12% year on year, earnings up +81% year on year, and operating margin widening (+3.6 points).

3 good

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.

Earnings trend+81% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+3.6 points operating

Trailing-twelve-month operating margin, 9.6% now against 5.9% a year earlier.

All from SEC EDGAR, as of Jul 3, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is NVST growing?

Envista Holdings Corporation has grown revenue 3.4% a year over three years and 3.4% a year over five, with earnings per share compounding at −22%.

+3.4%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +3.4%
Revenue growth, 5-year rate · +3.4% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −22%
Earnings per share, 3-year rate · revenue +3.4% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed